| scholarly article | Q13442814 |
| P356 | DOI | 10.1067/MAI.2002.122465 |
| P698 | PubMed publication ID | 11941315 |
| P50 | author | Ian M. Adcock | Q38803002 |
| Kian Fan Chung | Q43222898 | ||
| Peter J. Barnes | Q7174846 | ||
| P2093 | author name string | Atsushi Takahashi | |
| John G Matthews | |||
| Elvis Irusen | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | asthma | Q35869 |
| phosphorylation | Q242736 | ||
| P1104 | number of pages | 9 | |
| P304 | page(s) | 649-657 | |
| P577 | publication date | 2002-04-01 | |
| P1433 | published in | The Journal of Allergy and Clinical Immunology | Q7743550 |
| P1476 | title | p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma | |
| P478 | volume | 109 |
| Q50734141 | 13th European Respiratory Society Annual congress |
| Q43251106 | A randomized, placebo-controlled study of the effects of the p38 MAPK inhibitor SB-681323 on blood biomarkers of inflammation in COPD patients |
| Q34132234 | AMPK regulates metabolic actions of glucocorticoids by phosphorylating the glucocorticoid receptor through p38 MAPK |
| Q92764797 | Adipose-derived mesenchymal stem cells ameliorate acute liver injury in rat model of CLP induced-sepsis via sTNFR1 |
| Q41014465 | Altered mRNA Levels of Glucocorticoid Receptor, Mineralocorticoid Receptor, and Co-Chaperones (FKBP5 and PTGES3) in the Middle Frontal Gyrus of Autism Spectrum Disorder Subjects |
| Q24317463 | Altered subcellular distribution of MSK1 induced by glucocorticoids contributes to NF-kappaB inhibition |
| Q35021922 | Anthrax lethal factor represses glucocorticoid and progesterone receptor activity |
| Q44730526 | Asthma exacerbations after glucocorticoid withdrawal reflects T cell recruitment to the airway |
| Q38121086 | Asthma: beyond corticosteroid treatment |
| Q37596127 | Basal p38 mitogen-activated protein kinase regulates unliganded glucocorticoid receptor function in airway smooth muscle cells. |
| Q50483095 | Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis |
| Q35312155 | Biochemical basis of asthma therapy |
| Q38850404 | Blockade of interleukin-6 receptor enhances the anti-arthritic effect of glucocorticoids without decreasing bone mineral density in mice with collagen-induced arthritis |
| Q34594817 | Blood neutrophil activation markers in severe asthma: lack of inhibition by prednisolone therapy |
| Q38817408 | Bronchoprotection and bronchorelaxation in asthma: New targets, and new ways to target the old ones |
| Q37733518 | Challenges of treating asthma in people who smoke |
| Q34349236 | Circulating cortisol-associated signature of glucocorticoid-related gene expression in subcutaneous fat of obese subjects |
| Q36645790 | Clinical and molecular aspects of glucocorticoid resistant asthma |
| Q35557420 | Corticosteroid insensitive alveolar macrophages from asthma patients; synergistic interaction with a p38 mitogen-activated protein kinase (MAPK) inhibitor |
| Q36619748 | Corticosteroid insensitivity is reversed by formoterol via phosphoinositide-3-kinase inhibition |
| Q36626278 | Corticosteroid insensitivity of chemokine expression in airway smooth muscle of patients with severe asthma |
| Q38021518 | Corticosteroid resistance and novel anti-inflammatory therapies in chronic obstructive pulmonary disease: current evidence and future direction. |
| Q36637914 | Cross-talk between nuclear receptors and nuclear factor kappaB. |
| Q33636430 | Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases |
| Q36637116 | Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression |
| Q38915978 | Cytokine-induced loss of glucocorticoid function: effect of kinase inhibitors, long-acting β(2)-adrenoceptor [corrected] agonist and glucocorticoid receptor ligands |
| Q36369952 | Cytokines alter glucocorticoid receptor phosphorylation in airway cells: role of phosphatases. |
| Q36101717 | Cytokines and glucocorticoid receptor signaling. Relevance to major depression |
| Q28741172 | Defects of protein phosphatase 2A causes corticosteroid insensitivity in severe asthma |
| Q38209438 | Defining phenotypes in asthma: a step towards personalized medicine |
| Q37708682 | Diagnosis and management of eosinophilic asthma: a US perspective |
| Q89682925 | Dietary Advanced Glycation Endproducts Decrease Glucocorticoid Sensitivity In Vitro |
| Q40553683 | Enhancement of MEK/ERK signaling promotes glucocorticoid resistance in CD4+ T cells |
| Q34738020 | Evaluation of glucocorticoid receptor function in COPD lung macrophages using beclomethasone-17-monopropionate |
| Q48292059 | Fluoxetine signature on hippocampal MAPK signalling in sex-dependent manner |
| Q37121905 | Functional KCa3.1 channels regulate steroid insensitivity in bronchial smooth muscle cells |
| Q39098740 | Genetic variation in the glucocorticoid pathway involved in interindividual differences in the glucocorticoid treatment |
| Q28761895 | Glucocorticoid insensitivity as a future target of therapy for chronic obstructive pulmonary disease |
| Q47378060 | Glucocorticoid receptor isoforms alpha and beta in in vitro cytokine-induced glucocorticoid insensitivity |
| Q34414680 | Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy. |
| Q37020166 | Glucocorticoid receptor physiology |
| Q37501546 | Glucocorticoid resistance in inflammatory diseases. |
| Q57384887 | Glucocorticoid-resistant asthma |
| Q38127243 | Glucocorticoid-resistant asthma: more than meets the eye. |
| Q28073962 | Glucocorticoids and chronic inflammation |
| Q35093797 | Glucocorticoids: new mechanisms and future agents |
| Q51354545 | Glucocorticosteroids. |
| Q34903070 | Glucocorticosteroids: current and future directions |
| Q39546998 | Heterogeneity of glucocorticoid resistance in patients with bronchial asthma |
| Q34473404 | How glucocorticoids control their own strength and the balance between pro- and anti-inflammatory mediators |
| Q28657369 | How variability in clinical phenotypes should guide research into disease mechanisms in asthma |
| Q37078027 | IFN-gamma reverses IL-2- and IL-4-mediated T-cell steroid resistance |
| Q38447255 | Identifying a biomarker network for corticosteroid resistance in asthma from bronchoalveolar lavage samples. |
| Q24531350 | Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection |
| Q37670238 | Immunomodulatory role of thymulin in lung diseases. |
| Q34333963 | Impact of ozone exposure on the response to glucocorticoid in a mouse model of asthma: involvements of p38 MAPK and MKP-1. |
| Q34622463 | Increased frequency of dual-positive TH2/TH17 cells in bronchoalveolar lavage fluid characterizes a population of patients with severe asthma |
| Q37144416 | Increased glucocorticoid receptor beta alters steroid response in glucocorticoid-insensitive asthma |
| Q92639608 | Individual differences in inflammatory and oxidative mechanisms of stress-related mood disorders |
| Q64906046 | Inflammatory Signaling in Hypertension: Regulation of Adrenal Catecholamine Biosynthesis. |
| Q37526423 | Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder. |
| Q33664193 | Inhaled Corticosteroids |
| Q37532050 | Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future. |
| Q37192755 | Inhibition of lipopolysaccharide-stimulated chronic obstructive pulmonary disease macrophage inflammatory gene expression by dexamethasone and the p38 mitogen-activated protein kinase inhibitor N-cyano-N'-(2-{[8-(2,6-difluorophenyl)-4-(4-fluoro-2-me |
| Q41881199 | Interferon-alpha inhibits glucocorticoid receptor-mediated gene transcription via STAT5 activation in mouse HT22 cells |
| Q38346438 | Interleukin 1alpha (IL-1alpha) induced activation of p38 mitogen-activated protein kinase inhibits glucocorticoid receptor function |
| Q35047071 | Interleukin-10 and the regulation of mitogen-activated protein kinases: are these signalling modules targets for the anti-inflammatory action of this cytokine? |
| Q36834591 | Interleukin-13 signaling and its role in asthma |
| Q43505371 | Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitis |
| Q36392316 | Kinase inhibitors and airway inflammation. |
| Q38882099 | Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease. |
| Q35598838 | Ligand-independent phosphorylation of the glucocorticoid receptor integrates cellular stress pathways with nuclear receptor signaling |
| Q97537534 | Long non-coding RNA growth arrest specific-5: a potential biomarker for early diagnosis of severe asthma |
| Q39402899 | Mechanisms and treatments for severe, steroid-resistant allergic airway disease and asthma. |
| Q36643554 | Mechanisms of disease: regulation of glucocorticoid and receptor levels--impact on the metabolic syndrome |
| Q36237168 | Molecular and cellular mechanisms of pulmonary fibrosis |
| Q42703436 | Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease. |
| Q35054431 | Molecular mechanisms of corticosteroid actions in chronic inflammatory airway diseases. |
| Q34060256 | Neuroendocrine-immune interactions in rheumatoid arthritis: mechanisms of glucocorticoid resistance |
| Q35842492 | New anti-inflammatory therapies and targets for asthma and chronic obstructive pulmonary disease |
| Q35644663 | New asthma drugs acting on gene expression. |
| Q80810673 | New drugs for asthma |
| Q36245929 | New insights into the role and mechanism of macrophage migration inhibitory factor in steroid-resistant patients with systemic lupus erythematosus |
| Q38181697 | New treatments for severe treatment-resistant asthma: targeting the right patient |
| Q38162976 | Newer glucocorticosteroids and corticosteroid resistance reversal in asthma |
| Q38253844 | Novel agents in the future: Therapy beyond anti-TNF agents in inflammatory bowel disease |
| Q35040779 | Novel therapies for the treatment of inflammatory airway disease |
| Q36973604 | Oral corticosteroid-dependent asthma: a 30-year review |
| Q37756117 | Overcoming reduced glucocorticoid sensitivity in airway disease: molecular mechanisms and therapeutic approaches. |
| Q35532441 | Oxidants induce a corticosteroid-insensitive phosphorylation of histone 3 at serine 10 in monocytes |
| Q36822431 | Oxidative stress and steroid resistance in asthma and COPD: pharmacological manipulation of HDAC-2 as a therapeutic strategy |
| Q92891648 | P38 MAPK and glucocorticoid receptor crosstalk in bronchial epithelial cells |
| Q39001590 | PGE2 modulates the transcriptional activity of ERRa in prostate stromal cells |
| Q89949166 | PI3K inhibitor treatment ameliorates the glucocorticoid insensitivity of PBMCs in severe asthma |
| Q33810476 | Parainfluenza virus type 1 induces epithelial IL-8 production via p38-MAPK signalling |
| Q38003659 | Pathogenesis of severe asthma. |
| Q34381920 | Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids |
| Q39120165 | Pin1 promotes GR transactivation by enhancing recruitment to target genes |
| Q35842790 | Post-translational modifications of nuclear receptors and human disease |
| Q35937839 | Preventive effect of N-acetylcysteine in a mouse model of steroid resistant acute exacerbation of asthma. |
| Q34673237 | Pro-asthmatic cytokines regulate unliganded and ligand-dependent glucocorticoid receptor signaling in airway smooth muscle |
| Q40584191 | Protein phosphatase 5 mediates corticosteroid insensitivity in airway smooth muscle in patients with severe asthma. |
| Q36725196 | Protein tyrosine phosphatase PTP-RR regulates corticosteroid sensitivity. |
| Q47308169 | Quercetin restores corticosteroid sensitivity in cells from patients with chronic obstructive pulmonary disease |
| Q34788832 | Refractory asthma: mechanisms, targets, and therapy |
| Q37144279 | Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma |
| Q36516850 | Restoration of Corticosteroid Sensitivity in Chronic Obstructive Pulmonary Disease by Inhibition of Mammalian Target of Rapamycin |
| Q28728945 | Restoration of corticosteroid sensitivity by p38 mitogen activated protein kinase inhibition in peripheral blood mononuclear cells from severe asthma |
| Q35067454 | Reversal of corticosteroid insensitivity by p38 MAPK inhibition in peripheral blood mononuclear cells from COPD. |
| Q37187064 | Role of dual specificity phosphatases in biological responses to glucocorticoids. |
| Q38087650 | Role of transcription factors in the pathogenesis of asthma and COPD. |
| Q92886768 | Rosiglitazone Improves Glucocorticoid Resistance in a Sudden Sensorineural Hearing Loss by Promoting MAP Kinase Phosphatase-1 Expression |
| Q30422401 | Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program |
| Q36511445 | Single nucleotide polymorphisms of NR3C1 gene and recurrent depressive disorder in population of Poland |
| Q34949631 | Smoking in asthma is associated with elevated levels of corticosteroid resistant sputum cytokines-an exploratory study |
| Q90630036 | Steroid Receptors as MAPK Signaling Sensors in Breast Cancer: Let the Fates Decide |
| Q51040026 | Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: The role of thymic stromal lymphopoietin |
| Q51450884 | Systemic Corticosteroid Responses in Children with Severe Asthma: Phenotypic and Endotypic Features. |
| Q51051670 | T cells from burn-injured mice demonstrate a loss of sensitivity to glucocorticoids |
| Q37190220 | Th2 cytokine-induced upregulation of 11beta-hydroxysteroid dehydrogenase-1 facilitates glucocorticoid suppression of proasthmatic airway smooth muscle function |
| Q41926470 | The NS1 protein of Respiratory syncytial virus blocks glucocorticoid receptor nuclear translocation by targeting IPO13 may account for glucocorticoid insensitive |
| Q35155828 | The glucocorticoid receptor: a revisited target for toxins |
| Q37103363 | The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings |
| Q37524704 | The respiratory syncytial virus (RSV) nonstructural proteins mediate RSV suppression of glucocorticoid receptor transactivation |
| Q27675411 | The structural basis of direct glucocorticoid-mediated transrepression |
| Q47785792 | Therapeutic strategies for treatment of inflammation-related depression. |
| Q37573811 | Therapeutic targets for new therapy for corticosteroid refractory asthma |
| Q53085315 | Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation. |
| Q37362600 | Treating patients with respiratory disease who smoke |
| Q57070746 | Urban air pollution and climate change: "The Decalogue: Allergy Safe Tree" for allergic and respiratory diseases care |
| Q53851333 | Will it be steroids for ever? |
| Q38194600 | p38 MAPK inhibitors: a patent review (2012 - 2013). |
| Q54679387 | p38 MAPK regulates Th2 cytokines release in PBMCs in allergic rhinitis rats. |
| Q33947274 | p38 mitogen-activated protein kinase activates eNOS in endothelial cells by an estrogen receptor alpha-dependent pathway in response to black tea polyphenols. |
| Q35586057 | p38 mitogen-activated protein kinase-γ inhibition by long-acting β2 adrenergic agonists reversed steroid insensitivity in severe asthma |
Search more.